Live feed
Filing
SC 13G
SC 13G0001104659-15-011351·Adamas Pharmaceuticals Inc
Schedule 13G ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,021,788
- Percent of class
- 11.8100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-011351
- Form type
- SC 13G
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Feb 17, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership